MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154789 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Hossein Moutabian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Sciences Research Center (RSRC), AJA University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Epithelial-Mesenchymal Transition, Cell Movement, Neoplasm Invasiveness. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 439 Literaturangaben.
Abstract (Originalsprache)
Among the leading causes of death globally has been cancer. Nearly 90% of all cancer-related fatalities are attributed to metastasis, which is the growing of additional malignant growths out of the original cancer origin. Therefore, a significant clinical need for a deeper comprehension of metastasis exists. Beginning investigations are being made on the function of microRNAs (miRNAs) in the metastatic process. Tiny non-coding RNAs called miRNAs have a crucial part in controlling the spread of cancer. Some miRNAs regulate migration, invasion, colonization, cancer stem cells' properties, the epithelial-mesenchymal transition (EMT), and the microenvironment, among other processes, to either promote or prevent metastasis. One of the most well-conserved and versatile miRNAs, miR-155 is primarily distinguished by overexpression in a variety of illnesses, including malignant tumors. It has been discovered that altered miR-155 expression is connected to a number of physiological and pathological processes, including metastasis. As a result, miR-155-mediated signaling pathways were identified as possible cancer molecular therapy targets. The current research on miR-155, which is important in controlling cancer cells' invasion, and metastasis as well as migration, will be summarized in the current work. The crucial significance of the lncRNA/circRNA-miR-155-mRNA network as a crucial regulator of carcinogenesis and a player in the regulation of signaling pathways or related genes implicated in cancer metastasis will be covered in the final section. These might provide light on the creation of fresh treatment plans for controlling cancer metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiation Sciences Research Center (RSRC), AJA University of Medical Sciences, Tehran, Iran.
- College of Pharmacy, National University of Science and Technology, Dhi Qar, Iraq.
- Department of Dentistry, Al-Noor University College, Nineveh, Iraq.
- Pharmacy College, Al-Farahidi University, Iraq.
- Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144402, India.
Zitieren
APA
Moutabian, H., Radi, U. K., Saleman, A. Y., Adil, M., Zabibah, R. S., Chaitanya, M. N. L., Saadh, M. J., Jawad, M. J., Hazrati, E., Bagheri, H., Pal, R. S., & Akhavan-Sigari, R. (2023). MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154789
Vancouver
Moutabian H, Radi UK, Saleman AY, Adil M, Zabibah RS, Chaitanya MNL, et al. MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154789
BibTeX
@article{Moutabian2023,
author = {Moutabian, Hossein and Radi, Usama Kadem and Saleman, Abdulkarem Younis and Adil, Mohaned and Zabibah, Rahman S and Chaitanya, Mv N L and Saadh, Mohamed J and Jawad, Mahmood Jasem and Hazrati, Ebrahi and Bagheri, Hamed and Pal, Rashmi Saxena and Akhavan-Sigari, Reza},
title = {MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154789}
}
EUVIMED